Výsledky vyhledávání - "Ponni Subbiah"

Gabapentin for the treatment of painful diabetic neuropathy: dosing to achieve optimal clinical response

Autor: Bruce Parsons, Ponni Subbiah, Pablo Aschner, Elizabeth M Mutisya, Osvaldo J. M. Nascimento, Marino Tagle, Francisco J Gómez-Pérez, Armando Perez-Monteverde, Klaus Fichtner

Publikováno v: The British Journal of Diabetes & Vascular Disease. 4:173-178

Objective To determine whether gabapentin titrated to achieve clinical effect (≥ 50% reduction in pain; 900—3,600 mg/day) provides superior efficacy to a commonly prescribed fixed-dose (900 mg/day) in subjects with PDN. Methods In Latin America,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bbef1946ee8ae904bc17df63feae430
https://doi.org/10.1177/14746514040040030601

Zobrazit plný text záznamu

Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden

Autor: Howard Feldman, Serge Gauthier, Jane Hecker, Bruno Vellas, Birol Emir, Vera Mastey, Ponni Subbiah, null The Donepezil MSAD Study Investigat

Publikováno v: Journal of the American Geriatrics Society. 51:737-744

OBJECTIVES: This study investigated the efficacy of donepezil treatment on activities of daily living (ADLs) and social functioning in patients with moderate to severe Alzheimer's disease (AD) and the possible benefits of this treatment on caregiving

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117fbe49cbb04e69f507afad74ef881d
https://doi.org/10.1046/j.1365-2389.2003.51260.x

Zobrazit plný text záznamu

An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

Autor: Knut Engedal, Vera Mastey, A.-L. Wetterholm, Frans R.J. Verhey, Robert Miceli, Richard Zhang, Gunhild Waldemar, Anders Wimo, Hilkka Soininen, Bengt Winblad, Anders Haglund, Warren Chin, Ponni Subbiah

Publikováno v: Dementia and Geriatric Cognitive Disorders. 15:44-54

The costs and consequences of donepezil versus placebo treatment in patients with mild to moderate Alzheimer’s disease (AD) were evaluated as part of a 1-year prospective, double-blind, randomized, multinational clinical trial. Patients received ei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9728ded06108ae1870f27d5dc4559f31
https://doi.org/10.1159/000066669

Zobrazit plný text záznamu

Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease

Autor: David Ames, Ponni Subbiah, Jane Hecker, Howard Feldman, Serge Gauthier, Birol Emir, Bruno Vellas, Edward Whalen

Publikováno v: International Psychogeriatrics. 14:389-404

Objective: This subanalysis of a large, double-blind, placebo-controlled trial examined the prevalence of behavioral symptoms in moderate to severe Alzheimer's disease (AD), and the effect of treatment with donepezil. Methods: Two hundred ninety pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1537116a91f41b697f0f6c455f3d37fa
https://doi.org/10.1017/s104161020200858x

Zobrazit plný text záznamu

Stereological Analysis of Cerebral Atrophy in Human Immunodeficiency Virus-associated Dementia

Autor: Helen L. Fedor, Peter R. Mouton, Ponni Subbiah, Justin C. McArthur, Jonathan D. Glass

Publikováno v: Journal of Neuropathology and Experimental Neurology. 55:1032-1037

Brain atrophy is a common finding in patients with AIDS, but the relationship of atrophy to HIV-associated dementia is unclear. We used unbiased, stereological methods on postmortem brain specimens to estimate volumes of different brain regions in pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0ad135f19ff614da73a3492d81b144f
https://doi.org/10.1097/00005072-199655100-00003

Zobrazit plný text záznamu

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease

Autor: Howard Feldman, Ponni Subbiah, Bruno Vellas, Serge Gauthier, Birol Emir, Jane Hecker

Publikováno v: Current medical research and opinion. 18(6)

To investigate the efficacy and safety of donepezil in a subgroup of patients with Alzheimer's disease (AD) of moderate severity from a previous trial.Two hundred and seven patients with moderate AD (standardized Mini-Mental State Examination [sMMSE]

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec63d5356bf6df7634232a2511795e9
https://pubmed.ncbi.nlm.nih.gov/12442882

Zobrazit plný text záznamu

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

Autor: Jane Hecker, Howard Feldman, Bruno Vellas, Ed Whalen, Serge Gauthier, Ponni Subbiah

Publikováno v: Scopus-Elsevier

To investigate the efficacy and safety of donepezil in patients with moderate to severe AD (standardized Mini-Mental State Examination [sMMSE] scores of 5 to 17; Functional Assessment Staging scoreor =6 at baseline).Two-hundred ninety patients were r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f108cfc35829a4ea034699bf7e06e35
https://pubmed.ncbi.nlm.nih.gov/11874284

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání